{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:17:26Z","timestamp":1790331446085,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.leukres.2010.05.005","type":"journal-article","created":{"date-parts":[[2010,6,3]],"date-time":"2010-06-03T08:40:23Z","timestamp":1275554423000},"page":"e286-e287","source":"Crossref","is-referenced-by-count":5,"title":["Overdose with 16,000mg of imatinib mesylate"],"prefix":"10.1016","volume":"34","author":[{"given":"Emilie","family":"Dehours","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Riu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Chatelut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Recher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Fourcade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2010.05.005_bib1","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCRABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2010.05.005_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ajh.20486","article-title":"Imatinib mesylate as a cause of acute liver failure","volume":"81","author":"Cross","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2010.05.005_bib3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s10620-006-9117-1","article-title":"Imatinib mesylate (gleevec) hepatotoxicity","volume":"52","author":"Mindikoglu","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.leukres.2010.05.005_bib4","first-page":"75","article-title":"Imatinib (gleevec)-induced hepatotoxicity","volume":"39","author":"Ayuob","year":"2005","journal-title":"J Clin Gastroeneterol"},{"key":"10.1016\/j.leukres.2010.05.005_bib5","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1038\/sj.leu.2402702","article-title":"Imatinib mesylate induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis","volume":"16","author":"Ohyashiki","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2010.05.005_bib6","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/sj.leu.2402910","article-title":"Histological features of acute hepatitis after imatinib mesylate treatment","volume":"17","author":"James","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2010.05.005_bib7","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0399-8320(04)95160-3","article-title":"Imatinib mesylate-induced acute cytolytic hepatitis","volume":"28","author":"Rocca","year":"2004","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.leukres.2010.05.005_bib8","first-page":"979","article-title":"The use of Imatinib (STI571) in chronic myeloid leukemia: some practical considerations","volume":"87","author":"Marin","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2010.05.005_bib9","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1182\/blood-2007-10-116475","article-title":"Study Group Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study","volume":"111","author":"Larson","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.05.005_bib10","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/annonc\/mdm458","article-title":"Overdose with 6400mg of imatinib: is it safe?","volume":"18","author":"Bhargav","year":"2007","journal-title":"Ann Oncol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610002493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610002493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T17:27:08Z","timestamp":1544462828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212610002493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0145212610002493"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2010.05.005","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}